[
  {
    "ts": "2025-11-12T11:53:00+00:00",
    "headline": "J&J's MedTech Unit Sales Improve: Will the Momentum Last?",
    "summary": "J&J's MedTech sales rose 5.6% in Q3, fueled by cardiovascular strength and strategic portfolio shifts toward high-growth markets.",
    "url": "https://finance.yahoo.com/news/j-js-medtech-unit-sales-115300526.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "ff9ee50d-fec9-335c-906f-0de78fbd22eb",
      "content": {
        "id": "ff9ee50d-fec9-335c-906f-0de78fbd22eb",
        "contentType": "STORY",
        "title": "J&J's MedTech Unit Sales Improve: Will the Momentum Last?",
        "description": "",
        "summary": "J&J's MedTech sales rose 5.6% in Q3, fueled by cardiovascular strength and strategic portfolio shifts toward high-growth markets.",
        "pubDate": "2025-11-12T11:53:00Z",
        "displayTime": "2025-11-12T11:53:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9fbd184faf399044b3daf708db81da25",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zOP0QBTzaiRh4w5CHkr79w--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9fbd184faf399044b3daf708db81da25.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SocztinenBkcdmCqGzbO3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9fbd184faf399044b3daf708db81da25.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/j-js-medtech-unit-sales-115300526.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/j-js-medtech-unit-sales-115300526.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "MDT"
            },
            {
              "symbol": "ABT"
            },
            {
              "symbol": "SYK"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T14:10:14+00:00",
    "headline": "Here’s Why Abbott Laboratories (ABT) Traded Down in Q3",
    "summary": "Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Growth & Income Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 500 Index continued its rally in the third quarter, ending the year-to-date returns at 13.7%. During this period, growth and momentum were key contributors to the […]",
    "url": "https://finance.yahoo.com/news/why-abbott-laboratories-abt-traded-141014448.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "1565a205-1943-3387-ae69-e136a330bb61",
      "content": {
        "id": "1565a205-1943-3387-ae69-e136a330bb61",
        "contentType": "STORY",
        "title": "Here’s Why Abbott Laboratories (ABT) Traded Down in Q3",
        "description": "",
        "summary": "Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Growth & Income Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 500 Index continued its rally in the third quarter, ending the year-to-date returns at 13.7%. During this period, growth and momentum were key contributors to the […]",
        "pubDate": "2025-11-12T14:10:14Z",
        "displayTime": "2025-11-12T14:10:14Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/7652279a980f5f87da9000f561a8d01e",
          "originalWidth": 768,
          "originalHeight": 430,
          "caption": "Oversold Abbott Laboratories (ABT) Could Offer a Healthy Dividend Opportunity",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3Cfaxsjhl5CPt7v.ZiYMCQ--~B/aD00MzA7dz03Njg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/7652279a980f5f87da9000f561a8d01e.cf.webp",
              "width": 768,
              "height": 430,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/DY7YK7WT_cmYCcdR66UkkA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/7652279a980f5f87da9000f561a8d01e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/why-abbott-laboratories-abt-traded-141014448.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-abbott-laboratories-abt-traded-141014448.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T15:28:00+00:00",
    "headline": "USA Dietary Supplements Market Forecast and Company Analysis Report 2025-2033 Featuring Amway, Abbott, Glanbia, Bayer, Pfizer, Suntory, Herbalife, Haleon, Otsuka, Bountiful",
    "summary": "The United States Dietary Supplements Market, projected to grow from US$ 54.24 billion in 2024 to US$ 103.56 billion by 2033, is driven by rising health awareness and demand for preventive healthcare, alongside growing fitness trends and an aging population. Busy lifestyles, online retail expansion, and innovation in supplement formulations further stimulate market growth. Popular for their role in enhancing immunity, fitness, and general health, dietary supplements include vitamins, minerals, a",
    "url": "https://finance.yahoo.com/news/usa-dietary-supplements-market-forecast-152800414.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "373966e3-e364-3c2c-bf7c-0b0fcbc1ac6d",
      "content": {
        "id": "373966e3-e364-3c2c-bf7c-0b0fcbc1ac6d",
        "contentType": "STORY",
        "title": "USA Dietary Supplements Market Forecast and Company Analysis Report 2025-2033 Featuring Amway, Abbott, Glanbia, Bayer, Pfizer, Suntory, Herbalife, Haleon, Otsuka, Bountiful",
        "description": "",
        "summary": "The United States Dietary Supplements Market, projected to grow from US$ 54.24 billion in 2024 to US$ 103.56 billion by 2033, is driven by rising health awareness and demand for preventive healthcare, alongside growing fitness trends and an aging population. Busy lifestyles, online retail expansion, and innovation in supplement formulations further stimulate market growth. Popular for their role in enhancing immunity, fitness, and general health, dietary supplements include vitamins, minerals, a",
        "pubDate": "2025-11-12T15:28:00Z",
        "displayTime": "2025-11-12T15:28:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/d897fb1843620977d9950230b105d59e",
          "originalWidth": 600,
          "originalHeight": 400,
          "caption": "U.S. Dietary Supplements Market",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/M8fHD3jhjZwE6S0npUHeLw--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/d897fb1843620977d9950230b105d59e.cf.webp",
              "width": 600,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/M74XtgFhaIG36hhPuiLDlw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/d897fb1843620977d9950230b105d59e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/usa-dietary-supplements-market-forecast-152800414.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/usa-dietary-supplements-market-forecast-152800414.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GL9.IR"
            },
            {
              "symbol": "BAYN.DE"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "HLF"
            },
            {
              "symbol": "HLN.L"
            },
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-11-12T14:48:24+00:00",
    "headline": "Whoop Is Considering Going Public in the Next Two Years, CEO Says",
    "summary": "Founder and Chief Executive Officer Will Ahmed said the business is well-positioned for an IPO now that it’s broadened its portfolio to include proprietary technology, hardware, software, analytics and other items, such as accessories and apparel.  While Ahmed has previously said Whoop is likely to go public, he hadn’t shared when that might happen.",
    "url": "https://finance.yahoo.com/news/whoop-considering-going-public-next-130009946.html",
    "source": "Bloomberg",
    "provider": "yfinance",
    "raw": {
      "id": "927c325d-d8a8-3c22-aec9-731edd0be87e",
      "content": {
        "id": "927c325d-d8a8-3c22-aec9-731edd0be87e",
        "contentType": "STORY",
        "title": "Whoop Is Considering Going Public in the Next Two Years, CEO Says",
        "description": "",
        "summary": "Founder and Chief Executive Officer Will Ahmed said the business is well-positioned for an IPO now that it’s broadened its portfolio to include proprietary technology, hardware, software, analytics and other items, such as accessories and apparel.  While Ahmed has previously said Whoop is likely to go public, he hadn’t shared when that might happen.",
        "pubDate": "2025-11-12T14:48:24Z",
        "displayTime": "2025-11-12T14:48:24Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/bloomberg_holding_pen_162/75f7aef99d782e65a8f14fa891496650",
          "originalWidth": 2200,
          "originalHeight": 1467,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_zg_T53gS6VxGRBTS9qsXQ--~B/aD0xNDY3O3c9MjIwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/bloomberg_holding_pen_162/75f7aef99d782e65a8f14fa891496650.cf.webp",
              "width": 2200,
              "height": 1467,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XqXy2UzuT.7qZklsgWG8IA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/bloomberg_holding_pen_162/75f7aef99d782e65a8f14fa891496650.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Bloomberg",
          "url": "https://www.bloomberg.com/company"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/whoop-considering-going-public-next-130009946.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/whoop-considering-going-public-next-130009946.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "WHOO.PVT"
            },
            {
              "symbol": "005930.KS"
            },
            {
              "symbol": "ABT"
            },
            {
              "symbol": "AAPL"
            },
            {
              "symbol": "DXCM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]